agilon health inc
NYSE:AGL
agilon health inc
NYSE:AGL
Price:
5.16 USD
-5.49%
Updated:
Apr 23, 2024
P/E
Price to Earnings
Price to Earnings
-8
Current
-57.1
Median
22.8
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-8
Market Cap
/
2.1B
Net Income
-262.6m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
agilon health inc
NYSE:AGL
|
2.1B USD | -8 | |
| US |
|
Cigna Corp
NYSE:CI
|
103.3B USD | 20 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
96.4B EUR | 19.9 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
89.7B USD | 10.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.9B EUR | 45.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 40.8 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.5B EUR | -26.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
14.4B USD | 17 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR | 23.3 | |
| US |
|
DaVita Inc
NYSE:DVA
|
11.8B USD | 17 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-16.9
2-Years Forward
P/E
-27.5
3-Years Forward
P/E
169
You don't have any saved screeners yet
